You are here: Industry Insights > Alkem

News List

Alkem Laboratories launches Ibuprofen, Famotidine tablets in US expresspharma
August 05, 2021
The company has launched the tablets in the strength of 800 mg/26.6 mg in the United States, following an approval from the US Food and Drug Administration (FDA).
Alkem Laboratories says US FDA inspection at Taloja facility ends with ‘zero’ observations expresspharma
August 02, 2021
Drug firm Alkem Laboratories yesterday said the US health regulator has conducted an inspection of its Taloja facility in Maharashtra, and it ended with ‘zero’ observations.
Alkem’s St Louis facility gets two observations from US FDA expresspharma
June 21, 2021
Alkem Laboratories informed that the US FDA has issued Form 483 with two observations for its manufacturing facility located in St Louis, US. The US FDA had conducted an inspection of the company’s manufacturing facility from 14-18, June 2021.
Alkem launches Perampil (Perampanel Tablets) expresspharma
June 11, 2021
Alkem has launched Perampil, at 2 mg – Rs 49/strip of 7 tablets, 4 mg – Rs 180/strip of 15 tablets and 6 mg – Rs 300/strip of 15 tablets.
Alkem launches Perampil (Perampanel Tablets) at affordable prices and improved patient access for epilepsy treatment in India firstwordpharma
June 11, 2021
Alkem Laboratories Ltd. (Alkem), one of the India’s leading pharmaceutical formulation development, manufacturing, and marketing companies, announces the launch of Perampil (Perampanel) tablets 2 mg/4 mg/6 mg on June 9th 2021 to make the treatment
Alkem launches anti-epileptic drug BRIVASURE (Brivaracetam) expresspharma
March 16, 2021
Alkem Laboratories announced the launch of Brivasure, an affordable anti-epileptic drug for the treatment of epilepsy in India.
Alkem launches favipiravir under brand name Alfluenza expresspharma
August 06, 2020
Favipiravir is approved by the DCGI restricted emergency use in India for the treatment of mild to moderate cases of COVID-19.
Alkem Labs gets EIR from USFDA for its Daman facility expressbpd
July 25, 2018
Shares of Alkem Laboratories today closed at INR 2,026.35 per scrip on BSE